| Vol. 3.48 – 8 December, 2022 |
| |
|
|
| Using primary nasal epithelial organoid cultures, researchers found the SARS-CoV-2 attached to motile cilia via the ACE2 receptor, then traversed the mucus layer, using motile cilia as tracks to access the cell body. [Cell] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers identified an alveolar-fated epithelial progenitor in human fetal lungs, which grew as self-organizing organoids that modeled key aspects of cell lineage commitment. [Cell Stem Cell] |
|
|
|
| Using computational tools, organoids, and spatial tools, the authors showed that LY6D+ basosquamous cells represented a persister population lying on a central node along the skin lineage-associated spectrum of epithelial states. [Nature Communications] |
|
|
|
| Scientists identified a cohort of early-stage colorectal tumors, with aggressive features and a propensity to disseminate early, that were characterized by high epithelial cell-intrinsic TGFβ signaling. [Nature Communications] |
|
|
|
| Researchers constructed a placental barrier-brain organoid-on-a-chip model, which enabled them to investigate the effects of maternal PM2.5 exposure on the human fetal system including the placental barrier and fetal brain. [Science of the Total Environment] |
|
|
|
| The authors reported that CHD6 was highly expressed in colorectal cancer, and that CHD6 knockdown inhibited cancer cell proliferation, migration, invasion, and tumorigenesis. [Cell Discovery] |
|
|
|
| Investigators developed a simple dialysis-based medium conditioning that fully utilized growth factors accumulation to improve hepatic differentiation of human iPSCs at a high cell density. [Scientific Reports] |
|
|
|
| We prepared organoids using the cancer tissue-originated spheroid method from 61 patients with ovarian cancer. Chemosensitivity assays for paclitaxel and carboplatin were performed using the primary organoids from 50 patients who received the chemotherapy. [Human Cell] |
|
|
|
| 870 Liver-Chips were analyzed to determine their ability to predict drug-induced liver injury caused by small molecules identified as benchmarks by the Innovation and Quality consortium, who had published guidelines defining criteria for qualifying preclinical models. [Communications Medicine] |
| |
|
|
|
| Scientists review the current methods used to generate microglia-containing human brain organoids (MC-HBOs) and provide opinions on the use of MC-HBOs for disease modeling and functional studies. [Molecular Psychiatry] |
|
|
|
| The authors summarize the recent progress of novel approaches to engineering oral and maxillofacial organoids. They introduce the necessary components and their roles in forming oral and maxillofacial organoids. [iScience] |
|
|
|
|
| Crown Bioscience, Inc. and ERS Genomics Ltd. have signed a global license agreement for access to the foundational CRISPR/Cas9 patent portfolio held by ERS, which provides the company full license to operate globally using CRISPR/Cas9 for gene editing. [ERS Genomics Limited] |
|
|
|
|
| February 5 – 8, 2023 Keystone, Colorado, United States |
|
|
|
|
|
| Center for Nanomedicine and Tissue Engineering – Milan, Italy |
|
|
|
| Max Delbrück Center for Molecular Medicine – Berlin-Buch, Germany |
|
|
|
| Lund University – Lund, Sweden |
|
|
|
| Roche – Basel, Switzerland |
|
|
|
| University of Cambridge – Cambridge, England, United Kingdom |
|
|
|
|